Targets and Emerging Therapies for Schizophrenia
-
Form:Einzelkauf Download
-
Sprache:Englisch
-
eBook Format:PDF
- PDF Fr. 138.00 ausgewählt
- ePUB Fr. 138.00
Fr. 138.00
inkl. gesetzl. MwSt.Beschreibung
Produktdetails
Format
Kopierschutz
Ja
Family Sharing
Nein
Text-to-Speech
Nein
Erscheinungsdatum
06.06.2012
Herausgeber
Jeffrey S. Albert + weitereVerlag
WileySeitenzahl
486 (Printausgabe)
Dateigröße
22125 KB
Auflage
1. Auflage
Sprache
Englisch
EAN
9781118309384
New and emerging directions in pharmaceutical research to
better treat schizophrenia
Although the dopamine hypothesis has been the cornerstone of
schizophrenia therapeutics, it is clear that dopamine-based
approaches do not treat all aspects of the disease. Moreover, many
schizophrenia patients fail to respond to current antipsychotics.
Integrating chemistry, biology, and pharmacology, this book
explores emerging directions in pharmaceutical research for drug
targeting and discovery in order to find more effective treatments
for schizophrenia, one of the most serious and widespread
psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents
the basics of schizophrenia, drug targets for the disease, and
potential new drugs and therapeutics. It begins with a discussion
of prevalence and etiology. Then, it describes therapies such as
dopamine agonists and phosphodiesterase (PDE) inhibitors as well as
growing research aimed at addressing untreated symptoms. Next, the
authors discuss receptor modulators, inhibitors, and targeting
strategies for drug discovery. Both the neurobiological and
chemical aspects of all major pharmacological targets are
examined.
With contributions from an international team of pioneering
pharmaceutical researchers, this book compiles the current
knowledge in the field, setting the stage for new breakthroughs in
the treatment of schizophrenia. Targets and Emerging Therapies
for Schizophrenia:
* Provides a comprehensive resource for neuro-drug discovery and
the development of molecular targets for schizophrenia
treatment
* Draws from chemistry, biology, and pharmacology for more
effective drug targeting and discovery
* Explores a wide range of receptors and molecular targets,
including dopamine, PDEs, and neuropeptides
With Targets and Emerging Therapies for Schizophrenia as
their guide, drug discovery and development scientists have the
information they need to advance their own research so that new,
more effective treatments for schizophrenia will soon be a
reality.
better treat schizophrenia
Although the dopamine hypothesis has been the cornerstone of
schizophrenia therapeutics, it is clear that dopamine-based
approaches do not treat all aspects of the disease. Moreover, many
schizophrenia patients fail to respond to current antipsychotics.
Integrating chemistry, biology, and pharmacology, this book
explores emerging directions in pharmaceutical research for drug
targeting and discovery in order to find more effective treatments
for schizophrenia, one of the most serious and widespread
psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents
the basics of schizophrenia, drug targets for the disease, and
potential new drugs and therapeutics. It begins with a discussion
of prevalence and etiology. Then, it describes therapies such as
dopamine agonists and phosphodiesterase (PDE) inhibitors as well as
growing research aimed at addressing untreated symptoms. Next, the
authors discuss receptor modulators, inhibitors, and targeting
strategies for drug discovery. Both the neurobiological and
chemical aspects of all major pharmacological targets are
examined.
With contributions from an international team of pioneering
pharmaceutical researchers, this book compiles the current
knowledge in the field, setting the stage for new breakthroughs in
the treatment of schizophrenia. Targets and Emerging Therapies
for Schizophrenia:
* Provides a comprehensive resource for neuro-drug discovery and
the development of molecular targets for schizophrenia
treatment
* Draws from chemistry, biology, and pharmacology for more
effective drug targeting and discovery
* Explores a wide range of receptors and molecular targets,
including dopamine, PDEs, and neuropeptides
With Targets and Emerging Therapies for Schizophrenia as
their guide, drug discovery and development scientists have the
information they need to advance their own research so that new,
more effective treatments for schizophrenia will soon be a
reality.
Kundinnen und Kunden meinen
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kund*innen durch Ihre Meinung